Share on LinkedInShare on LinkedIn

ARTICLE · 16 JANUARY 2022

Modifications To Canada's Special Access Program: Implications On Medical Access To Amphetamines, Psilocybin, LSD And More

On January 5, 2022 the Canadian Government amended the Food and Drug Regulations to allow healthcare practitioners to apply, on a case-by-case basis, to the Minister of Health for special access to a certain class of "restricted drugs" ...

CanadaFood, Drugs, Healthcare, Life Sciences

Overview:

On January 5, 2022 the Canadian Government amended the Food and Drug Regulations to allow healthcare practitioners to apply, on a case-by-case basis, to the Minister of Health (the "Minister") for special access to a certain class of "restricted drugs" including amphetamines, psilocybin and lysergic acid diethylamide (LSD). Further, the January 5, 2022 amendments simplify the framework of regulation over all forms of cocaine in Canada, thereby reducing complexity for stakeholders applying to conduct activities with cocaine (e.g. research).

Restricted Drugs:

The Canadian Government regulates the possession, sale, importation/exportation and use of controlled substances through the Controlled Drugs and Substances Act and the Food and Drugs Act. Between the Controlled Drugs and Substances Act and the Food and Drugs Act, and their associated regulations, controlled substances in Canada are sub-divided into four categories of substances, consisting of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from